Details for 2013822166
Up to date per 20.04.2026
Actions
Details for 2013822166
Deleted
European Patent
03.06.2015 A
05.07.2023 B1
24.07.2012
US
201261675286 P
25.01.2013
US
201361756983 P
17.05.2013
US
201361824818 P
A61K 9/00 20060101AFI20221214BHEP
Owner
Avalyn Pharma Inc.12636 High Bluff Drive, Suite 400 San Diego, CA 92130US
Representative
No representatives present
Inventor
SURBER, Mark, William3773 Wellborn Street San Diego, CA 92103US